Piperidolate
From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Chemical compound
Pharmaceutical compound
| Clinical data | |
|---|---|
| Trade names | Dactil |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.001.318 Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C21H25NO2 |
| Molar mass | 323.436g·mol−1 |
| 3D model (JSmol) | |
| |
| [画像:X mark]N[画像:check]Y(what is this?) (verify) | |
Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2] [3] It was first approved in 1954 and is no longer marketed in the United States.[1]
References
- 1 2 "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
- ↑ "Piperidolate". drugs.com.
- ↑ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.
Stub icon
This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by adding missing information.